Status:

COMPLETED

The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients

Lead Sponsor:

RDD Pharma Ltd

Conditions:

Fecal Incontinence

Spinal Cord Injury

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

PHASE2

Brief Summary

This is an double blinded, cross-over study to determine the effect of Oxymetazoline gel on anal resting pressure and fecal incontinence in patients with spinal cord injury. Approximately 17 subjects ...

Eligibility Criteria

Inclusion

  • Signed written informed consent.
  • Male or female subjects 18 to 55 years of age;
  • Spinal Cord Injury that occurred at least 3 months from randomization day and less than 3 years from randomization day.
  • At least 4 unwanted/unexpected incontinent events/week

Exclusion

  • Known allergy to Oxymetazoline or silicone.
  • Pregnancy or lactation.
  • Active cardiovascular or cerebrovascular disease including unstable angina, myocardial infarction, transient ischemic attacks/stroke, clinically significant arrhythmia, congestive heart failure, or cardiac valve abnormalities;
  • Type 1 diabetes mellitus;
  • Insulin treated type 2 diabetes mellitus;
  • Renal insufficiency.
  • Liver insufficiency.
  • Malignant disease within 5 years of screening;
  • History of rectal surgery.
  • History of HIV, hepatitis B, hepatitis C.
  • Has upon physical examination a rectal deformation or signs of rectal disease such as fissure, bleeding hemorrhoids, fistula, infection or space occupying lesion.
  • Has used, in the last 1 week, drugs that may affect blood coagulation, such as Aspirin (at a dose above 500 mg/day), Warfarin, Sintrom, Enoxaparin, Nadroparin, Heparin, Clopidogrel, Ticlopidine.
  • Hypertension (blood pressure over 150/105 mm Hg in screening visit)
  • Unable to understand the use instruction, as judged by the investigator.

Key Trial Info

Start Date :

November 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2015

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT02299557

Start Date

November 1 2014

End Date

July 1 2015

Last Update

July 28 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Semmelweis Egyetem I. sz. Belgyógyászati Klinika

Budapest, Hungary